Drug, Cosmetic & Toiletry Wholesaling in the US
The success of the Drug, Cosmetic and Toiletry Wholesaling industry is driven by demand for its primary product segment, pharmaceuticals. The vast majority of industry revenue is sourced from the distribution of prescription and nonprescription drugs to a variety of retailers and healthcare providers. Over the five years to 2018, several major brand-name drugs have lost patent exclusivity. This has created an opportunity for less-expensive generic drugs to enter the market. Nevertheless, wholesalers have prepared for the expanded use of generic drugs and adjusted their prices and supplies accordingly. Consequently, industry revenue is expected to increase. Consolidation within the industry increased over the past five years and the industry is marked by a high degree of competition between leading operators. Over the five years to 2023, the Drug, Cosmetic and Toiletry Wholesaling industry is anticipated to keep growing due to increasing demand for industry products and an expanding elderly population.
Drug, cosmetic and toiletry wholesalers primarily distribute pharmaceutical products intended for internal and external consumption, such as tablets, capsules, vials, ointments and powders. The industry includes a range of biological and medical products, and botanical drugs and herbs. The industry does not include businesses that primarily distribute surgical, dental or hospital equipment.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook